Andreas Zuckermann
Overview
Explore the profile of Andreas Zuckermann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
168
Citations
3238
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lansac E, Veen K, Joseph A, Jaber P, Sossi F, Das-Gupta Z, et al.
Innovations (Phila)
. 2025 Feb;
:15569845241269309.
PMID: 39968696
Objective: Globally significant variation in treatment and course of heart valve disease (HVD) exists, and outcome measurement is procedure focused instead of patient focused. This article describes the development of...
2.
Lansac E, Veen K, Joseph A, Jaber P, Sossi F, Das-Gupta Z, et al.
JACC Adv
. 2025 Feb;
:101059.
PMID: 39966045
Background: Globally significant variation in treatment and course of heart valve disease (HVD) exists, and outcome measurement is procedure focused instead of patient focused. This article describes the development of...
3.
Lansac E, Veen K, Joseph A, Jaber P, Sossi F, Das-Gupta Z, et al.
Eur J Cardiothorac Surg
. 2025 Feb;
67(2).
PMID: 39957685
Background: Globally significant variation in treatment and course of heart valve disease (HVD) exists, and outcome measurement is procedure focused instead of patient focused. This article describes the development of...
4.
Lansac E, Veen K, Joseph A, Jaber P, Sossi F, Das-Gupta Z, et al.
Eur Heart J Qual Care Clin Outcomes
. 2025 Feb;
PMID: 39957667
Background: Globally significant variation in treatment and course of heart valve disease (HVD) exists, and outcome measurement is procedure focused instead of patient focused. This article describes the development of...
5.
Lansac E, Veen K, Joseph A, Jaber P, Sossi F, Das-Gupta Z, et al.
Circ Cardiovasc Qual Outcomes
. 2025 Feb;
:e000128.
PMID: 39957624
Background: Globally significant variation in treatment and course of heart valve disease (HVD) exists, and outcome measurement is procedure focused instead of patient focused. This article describes the development of...
6.
DAlessandro D, Zuckermann A
Ann Cardiothorac Surg
. 2025 Feb;
14(1):28-36.
PMID: 39944507
For most of the last almost 60 years of heart transplantation, static ice storage has been the dominant means of organ preservation. This method has allowed about 4 hours of...
7.
8.
Alam A, Lee C, Kanwar M, Moayedi Y, Bernhardt A, Takeda K, et al.
J Heart Lung Transplant
. 2024 Dec;
PMID: 39730081
Heart transplantation remains a critical therapy for patients with end-stage heart failure, offering incremental survival and improved quality of life. One of the key components behind the success of heart...
9.
Rega F, Lebreton G, Para M, Michel S, Schramm R, Begot E, et al.
Lancet
. 2024 Aug;
404(10453):670-682.
PMID: 39153817
Background: Static cold storage (SCS) remains the gold standard for preserving donor hearts before transplantation but is associated with ischaemia, anaerobic metabolism, and organ injuries, leading to patient morbidity and...
10.
Augusto J, Benden C, Diekmann F, Zuckermann A
Front Immunol
. 2024 Jun;
15:1371554.
PMID: 38846942
Allograft rejection is a critical issue following solid organ transplantation (SOT). Immunosuppressive therapies are crucial in reducing risk of rejection yet are accompanied by several significant side effects, including infection,...